In their research, Tao et al. (2014) observed that estrogen-activated GPER inhibits miR-148a and stimulates the expression of human leukocyte antigen-G (HLA-G) in breast cancer (Tao et al., 2014). The gene discussed is HLA-G; the disease is breast carcinoma.